Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis
Niloofar Khairkhah, Mohammad Reza Aghasadeghi, Ali Namvar, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240577-e0240577
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Review on COVID‐19 diagnosis models based on machine learning and deep learning approaches
Zaid Abdi Alkareem Alyasseri, Mohammed Azmi Al‐Betar, Iyad Abu Doush, et al.
Expert Systems (2021) Vol. 39, Iss. 3
Open Access | Times Cited: 140
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
Ashwani Sharma, Tarun Virmani, Vipluv Pathak, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 76
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia
Jyotirmayee Dey, Soumya Ranjan Mahapatra, Suman Lata, et al.
Expert Review of Vaccines (2021) Vol. 21, Iss. 4, pp. 569-587
Closed Access | Times Cited: 87
Immunoinformatics-guided designing of epitope-based subunit vaccine from Pilus assembly protein of Acinetobacter baumannii bacteria
Soumya Ranjan Mahapatra, Jyotirmayee Dey, Aryan Jaiswal, et al.
Journal of Immunological Methods (2022) Vol. 508, pp. 113325-113325
Closed Access | Times Cited: 61
Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
Stanislav R. Kurpe, Sergei Y. Grishin, Alexey K. Surin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9552-9552
Open Access | Times Cited: 54
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
Kunsulu Zakaryа, Lespek Kutumbetov, Mukhit Orynbayev, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101078-101078
Open Access | Times Cited: 52
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
Niloofar Khairkhah, Azam Bolhassani, Elnaz Agi, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268251-e0268251
Open Access | Times Cited: 28
Recombinant vaccines in 2022: a perspective from the cell factory
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Woochang Hwang, Winnie Lei, Nicholas M. Katritsis, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 249-274
Open Access | Times Cited: 39
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2
Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, et al.
RSC Advances (2021) Vol. 11, Iss. 29, pp. 18103-18121
Open Access | Times Cited: 38
In silico analysis of the effect of HCV genotype-specific polymorphisms in Core, NS3, NS5A, and NS5B proteins on T-cell epitope processing and presentation
Samina Baig, Assel Berikkara, Ramsha Khalid, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
Wesam Elsayed Gawad, Yosra I. Nagy, Tamer M. Samir, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Pharma 4.0 Continuous mRNA Drug Products Manufacturing
Andreas Ouranidis, Christina Davidopoulou, Reald-Konstantinos Tashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1371-1371
Open Access | Times Cited: 25
Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study
Samira Sanami, Morteza Alizadeh, Masoud Nosrati, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104390-104390
Open Access | Times Cited: 23
A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2
Ehsan Jahangirian, Ghadir A. Jamal, MohammadReza Nouroozi, et al.
Immunogenetics (2021) Vol. 73, Iss. 6, pp. 459-477
Open Access | Times Cited: 23
Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
Ysrafil Ysrafil, Zulfiayu Sapiun, Indwiani Astuti, et al.
Bioimpacts (2022)
Open Access | Times Cited: 17
Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
Aasim, Ruchika Sharma, Chandragouda R. Patil, et al.
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Design and In Silico Validation of a Novel MZF-1-Based Multi-Epitope Vaccine to Combat Metastatic Triple Negative Breast Cancer
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Vaccines (2023) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 7
An in silico approach to study the role of epitope order in the multi-epitope-based peptide (MEBP) vaccine design
Muthu Raj Salaikumaran, Prasanna Sudharson Kasamuthu, Veeranarayanan Surya Aathmanathan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches
Meet Parmar, Ritik Thumar, Jigar Sheth, et al.
Structural Chemistry (2022) Vol. 33, Iss. 6, pp. 2243-2260
Open Access | Times Cited: 8
Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants
Nur Farhanah Arshad, Fariza Juliana Nordin, Lian Chee Foong, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306111-e0306111
Open Access | Times Cited: 1
Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design
Chin Peng Lim, Boon Hui Kok, Hui Ting Lim, et al.
Pathogens and Global Health (2022) Vol. 117, Iss. 2, pp. 134-151
Open Access | Times Cited: 6
In silico design of a multi-epitope Chimera from Aedes aegypti salivary proteins OBP 22 and OBP 10
Sathish Sankar
Journal of Vector Borne Diseases (2022) Vol. 59, Iss. 4, pp. 327-336
Open Access | Times Cited: 6
Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 27, Iss. 4, pp. 2303-2311
Open Access | Times Cited: 7
In silico based multi-epitope vaccine design against norovirus
M S Pallavi, Renuka Suravajhala, Prashanth Suravajhala, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 12, pp. 5696-5706
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top